Intensive Insulin Therapy and Acute Kidney Injury. Analysis Using RIFLE Criteria.
Completed
- Conditions
- KidneyInjury
- Registration Number
- NCT00738504
- Lead Sponsor
- Hospital Sao Domingos
- Brief Summary
The purpose of this study is to determine if intensive insulin therapy really reduces the incidence of acute kidney injury in critically ill patients, using for analysis the RIFLE criteria for definition of AKI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 337
Inclusion Criteria
- We included 337 adult patients, non pregnant, admitted from July 1, 2004 to December 31, 2006, to a 20-bed multidisciplinary ICU of a general hospital and to an 11-bed trauma center ICU that had at least two blood glucose levels above 150 mg/dl from three measurements obtained in the first 12 hours after admission.
Exclusion Criteria
- pregnant patients
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the renal function outcome, defined by the RIFLE criteria in patients submitted to two different regimens of glycemic control: a carbohydrate restrictive strategy and intensive insulin therapy.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Does intensive insulin therapy modulate RIFLE criteria-based AKI through specific insulin signaling pathways in critically ill patients?
How does intensive insulin therapy compare to standard glucose control protocols in preventing RIFLE-defined acute kidney injury in ICU patients?
What biomarkers predict response to intensive insulin therapy in reducing RIFLE-classified acute kidney injury in critical care?
What are the hypoglycemia management strategies associated with intensive insulin therapy in NCT00738504?
Are there combination therapies or competitor drugs for AKI prevention in critically ill patients beyond insulin-based approaches?
Trial Locations
- Locations (1)
Hospital Sao Domingos
🇧🇷Sao Luis, MA, Brazil